Cargando…

Elevated Serum Levels of IL-21 in Kawasaki Disease

PURPOSE: The serum level of immunoglobulin (Ig)E has been reported to be elevated in patients with Kawasaki disease (KD). We investigated whether interleukin (IL)-21, rather than IL-4, could be related to elevated serum levels of IgE in KD. METHODS: Sera from 48 patients with KD and 12 controls with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Yon Jung, Kim, Mi Hyun, Lee, Hae Yong, Uh, Young, Namgoong, Mee Kyung, Cha, Byung Ho, Chun, Jin-Kyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479229/ https://www.ncbi.nlm.nih.gov/pubmed/23115732 http://dx.doi.org/10.4168/aair.2012.4.6.351

Ejemplares similares

Interleukin-21 Receptor Gene Polymorphisms in Kawasaki Disease
por: Kim, Mi Hyun, et al.
Publicado: (2013)

Predicting Factors for Refractory Kawasaki Disease
por: Do, Young-Sun, et al.
Publicado: (2010)

Relationship Between Gallbladder Distension and Lipid Profiles in Kawasaki Disease
por: Kim, Ki-Won, et al.
Publicado: (2010)

Clinical characteristics and serum N-terminal pro-brain natriuretic peptide as a diagnostic marker of Kawasaki disease in infants younger than 3 months of age
por: Bae, Hyun Kyung, et al.
Publicado: (2014)

Mycoplasma pneumoniae infection in patients with Kawasaki disease
por: Lee, Mi Na, et al.
Publicado: (2011)

Variation in IL-21-secreting circulating follicular helper T cells in Kawasaki disease
por: Xu, Meng, et al.
Publicado: (2018)

Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact
por: Park, Hye Rim, et al.
Publicado: (2017)

Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease
por: Choi, Yu Mi, et al.
Publicado: (2012)

Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children
por: Engelberg, Rachel, et al.
Publicado: (2017)

Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
por: Cunha, Burke A., et al.
Publicado: (2010)

Polymorphisms of methylenetetrahydrofolate reductase are not a risk factor for Kawasaki disease in the Korean population
por: Yoon, Kyung Lim, et al.
Publicado: (2011)

Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease
por: Chen, Xi, et al.
Publicado: (2015)

Elevated serum IL-37 concentrations in patients with sepsis
por: Wang, Yong-Chun, et al.
Publicado: (2019)

High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease
por: Min, Dong Eun, et al.
Publicado: (2019)

The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease
por: Sun, Yameng, et al.
Publicado: (2020)

Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease
por: Kang, Hae-Ryong, et al.
Publicado: (2013)

Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease
por: Choi, Han Seul, et al.
Publicado: (2015)

Correlation between elevated platelet count and immunoglobulin levels in the early convalescent stage of Kawasaki disease
por: Han, Ji-Whan, et al.
Publicado: (2017)

Spontaneous defervescence and its prediction in the acute phase of Kawasaki disease
por: Shin, Eun Jung, et al.
Publicado: (2022)

Increased frequency of peripheral blood follicular helper T cells and elevated serum IL-21 levels in patients with knee osteoarthritis
por: Shan, Yuxing, et al.
Publicado: (2017)

IL-31 Associated with Coronary Artery Lesion Formation in Kawasaki Disease
por: Tseng, Wan-Ning, et al.
Publicado: (2014)

IL-10 Promoter Genetic Polymorphisms and Risk of Kawasaki Disease in Taiwan
por: Hsieh, Kai-Sheng, et al.
Publicado: (2011)

A Presumed Etiology of Kawasaki Disease Based on Epidemiological Comparison With Infectious or Immune-Mediated Diseases
por: Rhim, Jung-Woo, et al.
Publicado: (2019)

Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium
por: Lee, Jong-Keuk, et al.
Publicado: (2015)

Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide
por: Choi, Jung Eun, et al.
Publicado: (2018)

Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses
por: Park, Byung-Joon, et al.
Publicado: (2014)

Elevated serum IL-21 levels are associated with stable immune status in kidney transplant recipients and a mouse model of kidney transplantation
por: Guo, Luying, et al.
Publicado: (2020)

Kawasaki disease in infants
por: Yeom, Jung Sook, et al.
Publicado: (2013)

IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients
por: de Oliveira, Priscilla Stela Santana, et al.
Publicado: (2015)

Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness
por: Wang, Yue, et al.
Publicado: (2016)

Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
por: Uldrick, Thomas S, et al.
Publicado: (2012)

Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis
por: Shenoy, Vivek K., et al.
Publicado: (2016)

Hyponatremia and Syndrome of Inappropriate Antidiuretic Hormone Secretion in Kawasaki Disease
por: Lim, Goh-Woon, et al.
Publicado: (2010)

The Relationship Between Serum Pentraxin 3 and Central Obesity in ST-Segment Elevation Myocardial Infarction Patients
por: Shim, Byung-Ju, et al.
Publicado: (2010)

Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy
por: Kim, Jung Ok, et al.
Publicado: (2016)

Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
por: Lee, Taek Jin, et al.
Publicado: (2008)

Risk Factors for Failure of Initial Intravenous Immunoglobulin Treatment in Kawasaki Disease
por: Cha, Sungho, et al.
Publicado: (2008)

Insertion/Deletion Polymorphism of Angiotensin Converting Enzyme Gene in Kawasaki Disease
por: Shim, Yoon Hee, et al.
Publicado: (2006)

Elevated Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor-1 Levels in Refractory Kawasaki Disease
por: Lee, Yu-Ran, et al.
Publicado: (2022)

Serum Levels of Syndecan-1 in Patients With Kawasaki Disease
por: Luo, Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mabqhfi83psa93ooh4hbgo0g24